# clm_2FD264F5993C

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: total_equity  
value: 21,081,000,000 United States dollar  
valid_from: 2022-09-30  
valid_to: 2022-12-31  
published: 2022-11-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_9F042AE98A38  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences total equity: 21,081,000,000 United States dollar", as of 2022-09-30 (until 2022-12-31). Claim clm_2FD264F5993C, https://asof.is/claim/clm_2FD264F5993C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209522000027/0000882095-22-000027-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2022, filed 2022-11-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209522000027/0000882095-22-000027-index.htm (primary, SEC EDGAR 10-Q Q3 FY2022, published 2022-11-02)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | total_equity | 20,236,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_2FD264F5993C](/claim/clm_2FD264F5993C.md) | [clm_C2489C029177](/claim/clm_C2489C029177.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.